drug approvals

Where Are the New Antibiotics?With the threat of superbugs and the possibility of an antibiotic-less future, alternatives are needed now.
New FDA lead ushers in new eraScott Gottlieb, MD, was sworn in as the new FDA commissioner and ushers in a new era.
More Billion-Dollar Drugs, Faster Approvals, and Other Pharmaceutical Trends
More Billion-Dollar Drugs, Faster Approvals, and Other Pharmaceutical TrendsWhat’s been going on in the biopharmaceutical industry?
FDA approvals for specialty drugs to pick up in 2017Numerous specialty medications, generics, and biosimilars, are expected to be approved this year for cancer, inflammatory and autoimmune diseases, and other indications.
Four things health execs should know about the oncology pipeline
Four things health execs should know about the oncology pipelineHere’s how you can recognize changes in the oncology pipeline and maximize value related to cancer care.
Antidepressant drug pipeline: What to know
Antidepressant drug pipeline: What to knowThere are promising developments in the pipeline for patients with treatment-resistant depression.
Changing FDA regs impact dermatologists, patientsRecent actions around drug compounding, sunscreen ingredient approvals, drugs and medical devices, cosmetic product marketing and more will affect your practice. Stay informed.
Asthma drug pipeline: Prevalence, costs to increase
Asthma drug pipeline: Prevalence, costs to increaseAs asthma prevalence continues to rise in the adult and pediatric populations, U.S. healthcare spending on medications, especially branded inhalers, is expected to increase.
Personalized medicine approvals experience sharp increaseAnalysis finds scientific validation of personalized medicine’s ability to improve patient outcomes.
High-dose insulin pen hits marketEli Lilly & Company finally releases a high-dose insulin pen, which will help cut down on medication errors associated with the U-100 Humulin insulin pens.